Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine Pathology
Published in: Endocrine Pathology 1/2010

01-03-2010

The Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Back to the Drawing Board

Author: Juan Rosai

Published in: Endocrine Pathology | Issue 1/2010

Login to get access

Abstract

The encapsulated follicular variant of papillary carcinoma has become one of the most common diagnoses in thyroid tumor pathology. However, serious issues remain regarding the reproducibility of the diagnosis, its position in the scheme of thyroid neoplasms, and the clinical implications of the diagnosis. Strict morphologic criteria should be applied to its microscopic recognition, especially in regard to the nuclear features. The generally indolent behavior of this tumor should be recognized in order to avoid overtreatment.
Literature
1.
Ackerman LV. Surgical pathology. 1st Ed. St Louis: The CV Mosby Company; p. 244. 1953.
2.
Ackerman LV. Surgical pathology. 2nd Ed. St Louis: The CV Mosby Company; p. 296. 1959.
3.
Warren S, Meissner WA. Tumors of the Thyroid Gland, 1st Series, Section IV, Fasc. 14, Washington: Armed Forces Institute of Pathology; p. 36-8. 1953.
4.
Meissner WA, Warren S. Tumors of the Thyroid Gland, 2nd Series, Fasc. 4, Armed Forces Institute of Pathology; p. 50–2. 1969.
5.
Meissner WA. Tumors of the Thyroid Gland. 2nd series Fasc. 4 Suppl. Washington: Armed Forces Institute of Pathology; p. S-7. 1984.
6.
Lindsay S. Carcinoma of the thyroid gland: a clinical and pathologic study of 293 patients at the University of California Hospital. Springfield: Charles C Thomas; 1960.
7.
Chen KTK, Rosai J. Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol. 1:123-30, 1977.CrossRef
8.
Vickery AL Jr. Thyroid papillary carcinoma. Pathological and philosophical controversies. Am J Surg Pathol. 7:797-807, 1983CrossRefPubMed
9.
Renshaw AA, Gould EW. Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 117:19-21, 2002CrossRefPubMed
10.
Rosai J, Kuhn E, Carcangiu ML. Pitfalls in thyroid tumour pathology. Histopathology. 49:107-120, 2006CrossRefPubMed
11.
Rhoden KJ, Unger K, Salvatore G, Ylmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M, Zitzelsberger H, Tallini G. RET/Papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto’s thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab. 91:2414-23, 2006CrossRefPubMed
12.
Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder B K, Dillon D A, Giuliano A, Cirafici A M, Santoro M, Rosai J, Tallini G. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma. A search for the early precursors of papillary cancer. Am J Pathol. 160:2157-67, 2002PubMed
13.
Elsheikh TM, Asa SL, Chan JK, DeLellis RA, Heffess CS, LiVolsi VA, Wenig BM. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol 5:736, 2008CrossRef
14.
Hirokawa M, Carney JA, Goellner JR, DeLellis RA, Heffess CS, Katoh R, Tsujimoto M, Kakudo K. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol. 26:1508-14, 2002CrossRefPubMed
15.
Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, Chan JKC, DeLellis RA, Harach HR, Kakudo K, LiVolsi VA, Rosai J, Sebo JT, Sobrinho-Simoes M, Wenig BM, Lae ME. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 28:1336-40, 2004CrossRefPubMed
16.
Widder S, Guggisberg K, Khalil M, Pasieka JL. A pathologic re-review of follicular thyroid neoplasms: The impact of changing the threshold for the diagnosis of the follicular variant of papillary thyroid carcinoma. Surgery. 144:80-5, 2008CrossRefPubMed
17.
Lubitz CC, Ugras SK, Kazam JJ, Zhu B, Scognamiglio T, Chen YT, Fahey TJ 3rd. Microarray analysis of thyroid nodule fine-needle aspirates accurately classifies benign and malignant lesions. J Mol Diagnostics 8:490-8, 2006CrossRef
18.
Thompson LDR, Wienke JA, Paal E, Frommell RA, Adair CF, Heffess CS. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 91:505-24, 2001CrossRefPubMed
19.
Santarpia L, Sherman SI, Marabotti A, Clayman GL, El-Naggar AK. Detection and molecular characterization of a novel BRAF activated domain mutation in follicular variant of papillary thyroid carcinoma. Hum Pathol 40:827-33, 2009CrossRefPubMed
20.
Williams ED., On behalf of the Chernobyl Pathologists Group (Abrosimov A, Bogdanova T, Ilo M, Rosai J, Sidorov Y, Thomas GA). Guest editorial: two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 8:181–3, 2000CrossRefPubMed
Metadata
Title
The Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Back to the Drawing Board
Author
Juan Rosai
Publication date
01-03-2010
Publisher
Humana Press Inc
Published in
Endocrine Pathology / Issue 1/2010
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-009-9103-1

Other articles of this Issue 1/2010

Endocrine Pathology 1/2010 Go to the issue

EditorialNotes

Letter to the Editor

OriginalPaper

Determination of Cell Proliferation Using Mcm2 Antigen and Evaluation of Apoptosis and TGF-β1 Expression in GH-secreting or Clinically Nonfunctioning Pituitary Adenomas

ReviewPaper

Papillary Carcinoma Tall Cell Variant (TCV): A Review

OriginalPaper

Oncocytes, Oxyphils, Hürthle, and Askanazy Cells: Morphological and Molecular Features Of Oncocytic Thyroid Nodules

OriginalPaper

Poorly Differentiated Thyroid Carcinoma: 5 Years after the 2004 WHO Classification of Endocrine Tumours

OriginalPaper

Pituitary Adenomas that Show a Faint GH-Immunoreactivity but Lack Fibrous Body: Pit-1 Adenoma with Endocrinologically Low Activity
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits